Drug Trial Radar · NCT07920887
A Study of Bimagrumab in Participants With HFpEF
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
540
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Jul 2029
Study completion Nov 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will look at how bimagrumab affects adults who have a type of heart failure called HFpEF (heart failure with preserved ejection fraction), where the heart pumps normally but does not fill with blood as well as it should. Participation in the study will last about 76 weeks.
Conditions
- Heart Failure, Diastolic
- Diastolic Heart Failure
- Heart Failure, Normal Ejection Fraction
- Heart Failure, Preserved Ejection Fraction
Interventions
BimagrumabDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Kansas City Cardiomyopathy Questionnaire-Clinical Summary Score (KCCQ-CSS)Time frame: Baseline, Week 52
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
InvivoCure LLC
Van Nuys, California
Amavita Research Services, LLC
North Miami Beach, Florida
Dharma PA d/b/a Southwest Family Medicine Associates
Dallas, Texas
Semmelweis Egyetem - Varosmajori Sziv es Ergyogyaszati Klinika
Budapest, Hungary
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Sant' Anna e San Sebastiano di Caserta
Caserta, Italy
A.O. Ordine Mauriziano di Torino
Torino, Italy
Krakowski Szpital Specjalistyczny im. sw. Jana Pawla II
Krakow, Poland
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Wroclaw, Poland
4 Wojskowy Szpital Kliniczny z Poliklinika Samodzielny Publiczny ZOZ we Wroclawiu
Wroclaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.